The cancer-specific CD103+ T cell lines, sourced from seven different patients with cancer demonstrated positive surface expression of CD61 following activation either by agonistic αCD3/αCD28 antibody or following co-culture with antigenic cancer cells (Fig. 2a and Extended Data Fig. 4a). This evidence concerns the gene ITGB3 and cancer.